Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1 - PubMed (original) (raw)

Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1

L Solomin et al. J Virol. 1990 Dec.

Abstract

We have analyzed the action of the Rev and Tev proteins of human immunodeficiency virus type 1 (HIV-1) and of the Rex protein of human T-cell leukemia virus type I (HTLV-I) on a series of Rev-responsive element (RRE) mutants. The minimum continuous RRE region necessary and sufficient for Rev function was determined to be 204 nucleotides. Interestingly, this region was not sufficient for Tev or Rex function. These proteins require additional sequences, which may stabilize the structure of the RRE or may contain additional sequence-specific elements. Internal RRE deletions revealed that the targets for Rev and Rex can be separated, since mutants responding to Rev and not Rex and vice versa were identified. Tev was active on both types of mutants, suggesting that it has a more relaxed specificity than do both Rev and Rex proteins. Although Rev and Rex targets within the RRE appear to be distinct, the trans-dominant mutant RevBL prevents the RRE interaction with Rex. RevBL cannot inhibit the function of Rex on RRE deletions that lack the Rev-responsive portion. These results indicate the presence of distinct sites within the RRE for interaction with these proteins. The binding sites for the different proteins do not function independently and may interfere with one another. Mutations affecting the RRE may change the accessibility and binding characteristics of the different binding sites.

PubMed Disclaimer

Cited by

Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides.
Chin DJ. Chin DJ. J Virol. 1992 Jan;66(1):600-7. doi: 10.1128/JVI.66.1.600-607.1992. J Virol. 1992. PMID: 1727504 Free PMC article.
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein.
Dayton ET, Konings DA, Powell DM, Shapiro BA, Butini L, Maizel JV, Dayton AI. Dayton ET, et al. J Virol. 1992 Feb;66(2):1139-51. doi: 10.1128/JVI.66.2.1139-1151.1992. J Virol. 1992. PMID: 1731093 Free PMC article.
HTLV-1 Rex: the courier of viral messages making use of the host vehicle.
Nakano K, Watanabe T. Nakano K, et al. Front Microbiol. 2012 Sep 6;3:330. doi: 10.3389/fmicb.2012.00330. eCollection 2012. Front Microbiol. 2012. PMID: 22973269 Free PMC article.
Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN. Schwartz S, et al. J Virol. 1992 Dec;66(12):7176-82. doi: 10.1128/JVI.66.12.7176-7182.1992. J Virol. 1992. PMID: 1433510 Free PMC article.
In vivo binding of wild-type and mutant human immunodeficiency virus type 1 Rev proteins: implications for function.
Arrigo SJ, Heaphy S, Haines JK. Arrigo SJ, et al. J Virol. 1992 Sep;66(9):5569-75. doi: 10.1128/JVI.66.9.5569-5575.1992. J Virol. 1992. PMID: 1501291 Free PMC article.

References

1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
1. J Virol. 1990 Jun;64(6):2505-18 - PubMed
1. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3618-22 - PubMed
1. Nature. 1985 Jul 18-24;316(6025):262-5 - PubMed
1. J Virol. 1986 Aug;59(2):284-91 - PubMed

Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1 - PubMed (original) (raw)